Asahi Kasei Corporate Venture Capital

Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

Koya Medical, Inc. is a company based in Oakland, California, founded in 2018. It focuses on developing a connected wearable platform designed to address the significant unmet needs in the treatment of cancer-related chronic lymphedema and venous diseases. The technology aims to provide a drug-free solution for patients suffering from these conditions, enhancing their quality of life through innovative medical devices.

Rege Nephro Co., Ltd. engages in the research and development, production, and marketing of renal disease therapeutics using nephron progenitor cells. It also produces kidney organoids capable of nephrotoxicity screening for drug discovery in applied research. The company was founded in 2019 and is based in Kyoto, Japan.

Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings.

Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

Firework is one of the fastest growing interactive video platforms on mobile.

Shenzhen Dami He Xiaomi Cultural Broadcast Co., Ltd., known as Dami & Xiaomi, operates an online platform dedicated to supporting children with autism spectrum disorder. Founded in 2014 and based in Shenzhen, China, the company offers a range of integrated services, including rehabilitation, educational support, parent training, online courses, and informative resources. Dami & Xiaomi aims to create a comprehensive environment that fosters the development and well-being of children with autism, while also providing essential guidance and support for their families.

Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

Feldan Bio Inc. is a recombinant protein company based in Quebec, Canada, specializing in the discovery, development, manufacture, and marketing of recombinant proteins and molecular biology reagents for life science companies and research laboratories globally. The company has developed the Feldan Shuttle, a patented protein-based technology platform that facilitates the delivery of transcription factors and genome editing tools for clinical applications. Feldan Bio offers a wide range of products, including monoclonal antibodies, cell culture supplements, transfection reagents, and various growth factors and enzymes. Additionally, it provides research protein products and custom services such as protein expression, antibody generation, and custom peptide synthesis. The company also develops and licenses therapeutic proteins aimed at biopharmaceutical companies focusing on treatments for diseases like cancer and diabetes. Founded in 1999, Feldan Bio is committed to advancing therapeutic applications through its innovative technology platform.